- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT05102435
Translation and Validation of the Performance Oriented Mobility Assessment (Poma) Scale Into Urdu Version
Cross-cultural Translation and Validation of the Performance Oriented Mobility Assessment (Poma) Scale Into Urdu Version
Visão geral do estudo
Descrição detalhada
Among older persons, age-related impairments cause loss of postural control and balance that result in pain, independency and disability. One of the most common geriatric syndromes and most serious health issue threatening the independency of older persons is fall. The impact of these fall-related injuries on older person, families and societies and its fruitful intervention has made this issue important worldwide. Approximately 28-35% of people aged 65 years and 32-42% of aged 70 years' experience falls annually and 10% suffer serious injury such as, fracture, severe head trauma and joint dislocation. The incidence rate of fall is higher in hospitalized and residents of nursing home. It rises from middle age and peaks in person above 80 years. The risk factors associated with falls are, lower extremity muscle weakness, gait or balance deficits, use of an assistive device, cognitive impairment, visual deficit, arthritis and impaired activities of daily living . Different scales and tests are used for risk factors for falls, balance and mobility such as Berg Balance Scale, Time up and go test and dynamic gait index and Fullerton Advanced Balance Scale. One of these scales Performance-Oriented Mobility Assessment (POMA) scale. POMA scale has acceptable reliability and validity as compared to FRT and TUG in elderly. The advantages of this scale are; applicability, low cost, easy to administer, no equipment is needed other than a standard chair and stopwatch, evaluates functional activities and assesses both balance (POMA-B) and gait components (POMA-G)Originally POMA scale was used to assess risk of fall in institutionalized populations but later on used as an assessment tool for mobility and determine effects of interventions.
The POMA has found to be widely used in patients who have dynamic and reactive balance deficits. It comprises 16 items (9 balance and 7 gait related). Total time taken for administration is approximately 10 minutes and total score is 28; 16 is balance and 12 is gait score. Some Items are scored dichotomously (can/cannot perform) and others are scored 0, 1 or 2 points for quality of performance. The higher scores show low fall risk and better balance while lower score predicts poorer balance and greater risk of fall. The score 19-24/28 indicates moderate risk for falling while score <19 indicates a "high" risk for falling.
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
-
Rawalpindi, Paquistão, 46000
- Misbah Ghous
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- The sample will be assessed a cognition evaluation through the mini-mental test
- Any present or previous history of vertigo since last 6 months
Exclusion Criteria:
- Patients with any neurological disorder,
- previous orthopedic surgery within last 6 months,
- bedridden,
- wearing any prosthesis, and illiteracy.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Performance oriented mobility Assessment scale
Prazo: 1 time assessment of mobility and balance (approximately 10 minutes)
|
Performance oriented mobility Assessment scale is used to assess risk of fall in institutionalized populations but later on used as an assessment tool for mobility and balance assessment.
Total time taken for administration is approximately 10 minutes and total score is 28; 16 is balance and 12 is gait score
|
1 time assessment of mobility and balance (approximately 10 minutes)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Misbah ghous, MS, Riphah International University Islamabad
Publicações e links úteis
Publicações Gerais
- Yücel SD, Şahin F, Doğu B, Şahin T, Kuran B, Gürsakal S. Reliability and validity of the Turkish version of the Performance-Oriented Mobility Assessment I. European Review of Aging and Physical Activity. 2012 Oct;9(2):149-59.
- Schulein S, Pflugrad L, Petersen H, Lutz M, Volland-Schussel K, Gassmann KG. [German translation of the performance-oriented mobility assessment according to Tinetti]. Z Gerontol Geriatr. 2017 Aug;50(6):498-505. doi: 10.1007/s00391-016-1070-9. Epub 2016 Jun 16. German.
- Moulodi B, Azad A, Taghizadeh G, Roohi-Azizi M, Mohammadi P. Reliability and validity of persian version of performance-oriented mobility assessment (POMA) in Community-dwelling Iranian Older Adults: Psychometric Properties. Iranian Rehabilitation Journal. 2020;18(1):39-48.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- REC/00964 Kiran
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .